LYRA
Price
$6.85
Change
-$0.19 (-2.70%)
Updated
Sep 5 closing price
Capitalization
11.26M
VERA
Price
$24.19
Change
+$2.29 (+10.46%)
Updated
Sep 5 closing price
Capitalization
1.54B
58 days until earnings call
Interact to see
Advertisement

LYRA vs VERA

Header iconLYRA vs VERA Comparison
Open Charts LYRA vs VERABanner chart's image
Lyra Therapeutics
Price$6.85
Change-$0.19 (-2.70%)
Volume$14.03K
Capitalization11.26M
Vera Therapeutics
Price$24.19
Change+$2.29 (+10.46%)
Volume$2.75M
Capitalization1.54B
LYRA vs VERA Comparison Chart in %
Loading...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYRA vs. VERA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRA is a StrongBuy and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (LYRA: $6.85 vs. VERA: $24.19)
Brand notoriety: LYRA and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYRA: 52% vs. VERA: 200%
Market capitalization -- LYRA: $11.26M vs. VERA: $1.54B
LYRA [@Biotechnology] is valued at $11.26M. VERA’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYRA’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 1 green FA rating(s).

  • LYRA’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 1 green, 4 red.
According to our system of comparison, VERA is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYRA’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 6 bullish TA indicator(s).

  • LYRA’s TA Score: 4 bullish, 4 bearish.
  • VERA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than LYRA.

Price Growth

LYRA (@Biotechnology) experienced а -2.14% price change this week, while VERA (@Biotechnology) price change was +11.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

VERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.54B) has a higher market cap than LYRA($11.3M). LYRA YTD gains are higher at: -33.624 vs. VERA (-42.800). LYRA has higher annual earnings (EBITDA): -35.34M vs. VERA (-210.52M). VERA has more cash in the bank: 557M vs. LYRA (29.8M). LYRA has less debt than VERA: LYRA (32.5M) vs VERA (77.6M). LYRA has higher revenues than VERA: LYRA (770K) vs VERA (0).
LYRAVERALYRA / VERA
Capitalization11.3M1.54B1%
EBITDA-35.34M-210.52M17%
Gain YTD-33.624-42.80079%
P/E RatioN/AN/A-
Revenue770K0-
Total Cash29.8M557M5%
Total Debt32.5M77.6M42%
TECHNICAL ANALYSIS
Technical Analysis
LYRAVERA
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
81%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSDZX36.430.22
+0.61%
DWS Small Cap Growth R6
FEXRX12.000.06
+0.50%
First Eagle U.S. SMID Cap Opportunity R6
HBLYX15.320.03
+0.20%
Hartford Balanced Income Y
TRGPX23.330.02
+0.09%
Nuveen Quant Mid Cap Growth Premier
PGEOX27.62-0.01
-0.04%
George Putnam Balanced A

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-2.70%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
+17.93%
VERA - LYRA
54%
Loosely correlated
+10.46%
KYMR - LYRA
52%
Loosely correlated
+3.10%
CLNN - LYRA
39%
Loosely correlated
+1.34%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+10.46%
KYMR - VERA
58%
Loosely correlated
+3.10%
LYRA - VERA
54%
Loosely correlated
-2.70%
OPORF - VERA
50%
Loosely correlated
N/A
CRNX - VERA
39%
Loosely correlated
+3.97%
VYGR - VERA
38%
Loosely correlated
+9.28%
More